Publication:
The Role of Fibrinolytic System in No-Reflow After Stenting With and Without Predilation in Patients With Acute Coronary Syndromes: Fibrinolysis and No-Reflow After Coronary Stenting

dc.authorscopusid8563748300
dc.authorscopusid57214422126
dc.authorscopusid23473516300
dc.authorscopusid23472905600
dc.authorscopusid12139111700
dc.authorscopusid8607023600
dc.authorscopusid8607023600
dc.contributor.authorDemircan, S.
dc.contributor.authorYazící, M.
dc.contributor.authorHamiseyev, C.
dc.contributor.authorDemi̇Rcan, G.
dc.contributor.authorSultansuyu, S.
dc.contributor.authorYaşar, E.
dc.contributor.authorŞahin, M.
dc.date.accessioned2020-06-21T15:18:49Z
dc.date.available2020-06-21T15:18:49Z
dc.date.issued2007
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Demircan] Sabri, Department of Cardiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yazící] Mustafa, Department of Cardiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Hamiseyev] Cavid, Department of Cardiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Demi̇Rcan] Günnur, Faculty of Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Sultansuyu] Sevinç, Faculty of Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yaşar] Erdoǧan, Faculty of Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Şahin] Mahmut, Department of Cardiology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractBackground: No-reflow developed after coronary revascularization is an independent predictor of in-hospital mortality and poor clinical outcome. In this study, we investigated the difference between direct stenting and stenting with predilation, regarding to development of no-reflow in patients with acute coronary syndromes (ACS) and the role of fibrinolytic system in that phenomenon. Methods: Fifty eight patients with the diagnosis of ACS in whom percutaneous coronary intervention (PCI) was applied were included in study. Patients were divided into two groups according to stent application with and without predilation. Pre- and post-intervention corrected TIMI frame counts (cTFC) were calculated. Post-PCI plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA), plasminogen and D-Dimer levels were measured. Results: Pre-intervention cTFC values were similar between stenting with and without predilation groups (P > 0.05). There was a significant decrease in postintervention cTFC values in both groups (P < 0.002 and P < 0.05, respectively). But, there was no significant difference between post-intervention cTFC values of the groups, regardless to stent implantation techniques. (P > 0.05). In patients having high cTFC values compared with having low cTFC values; PAI-1 (P = 0.002), tPA (P = 0.015), plasminogen (P = 0.040) and D-dimer (P = 0.049) levels were significantly higher. Also, significant relationship was determined between cTFC and PAI-1, tPA, plasminogen, D-dimer levels (P values 0.003, <0.05, <0.05, and <0.002, respectively). Conclusions: Results of this study indicated an important role of increased fibrinolytic activity in development of no-reflow phenomenon after PCI. We didn't observe any differences between direct stenting and stenting with predilation according to the occurrence of no-reflow. © Springer Science+Business Media, LLC 2007.en_US
dc.identifier.doi10.1007/s11239-007-0012-1
dc.identifier.endpage114en_US
dc.identifier.issn0929-5305
dc.identifier.issue2en_US
dc.identifier.pmid17294139
dc.identifier.scopus2-s2.0-38449085828
dc.identifier.scopusqualityQ1
dc.identifier.startpage109en_US
dc.identifier.urihttps://doi.org/10.1007/s11239-007-0012-1
dc.identifier.volume24en_US
dc.identifier.wosWOS:000248794000005
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofJournal of Thrombosis and Thrombolysisen_US
dc.relation.journalJournal of Thrombosis and Thrombolysisen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFibrinolysisen_US
dc.subjectNo-Reflowen_US
dc.subjectStenten_US
dc.subjectTIMI Frame Counten_US
dc.titleThe Role of Fibrinolytic System in No-Reflow After Stenting With and Without Predilation in Patients With Acute Coronary Syndromes: Fibrinolysis and No-Reflow After Coronary Stentingen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files